Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
The Life Sciences Report
Menu
Articles
Biotechnology / Pharmaceuticals
Cannabis
Healthcare Services
Life Sciences Tools & Diagnostics
Medical Devices
Nutraceuticals
Psychedelics
Disclosures
Featured news in
The Life Sciences Report
3D Signatures Inc.
(DXD:TSX.V; TDSGF:OTCQB; 3D0:FSE)
3D Signatures Inc. Announces Short Form Prospectus Offering to Raise Up to C$5 Million (7/19/2017)
view
Inovio Pharmaceuticals Inc.
(INO:NASDAQ)
Inovio Announces Pricing of Public Offering of Common Stock (7/19/2017)
view
Celgene Corp.
(CELG:NASDAQ)
The Zacks Analyst Blog Highlights: Apple, JPMorgan, Celgene, PayPal and Vertex Pharmaceuticals (7/19/2017)
view
ProMIS Neurosciences Inc.
(PMN:TSX; PMN:NCM)
Announces Presentation of Data from Alzheimer’s Disease Program at AAIC 2017 (7/19/2017)
view
Caladrius Biosciences Inc.
(CLBS:NASDAQ)
Caladrius Biosciences Announces that 50% of Subjects Have Been Treated in the Phase 2 Clinical Trial of CLBS03 for Type 1 Diabetes (7/19/2017)
view
Inovio Pharmaceuticals Inc.
(INO:NASDAQ)
Inovio Announces Proposed Public Offering of Common Stock (7/18/2017)
view
Inovio Pharmaceuticals Inc.
(INO:NASDAQ)
Today's Research Reports on Trending Tickers: Inovio Pharmaceuticals Inc. and Universal Display Corporation (7/19/2017)
view
Celgene Corp.
(CELG:NASDAQ)
Celgene- Value in Cancer Treatments (7/17/2017)
view
Celgene Corp.
(CELG:NASDAQ)
Top Stock Reports for Apple, JPMorgan & Celgene (7/18/2017)
view
Celgene Corp.
(CELG:NASDAQ)
Amgen (AMGN) Gets CRL for Osteoporosis Drug Evenity's BLA (7/17/2017)
view
Celgene Corp.
(CELG:NASDAQ)
5 CAR-T Stocks in Focus as NVS Drug Wins FDA Advisory Panel Vote (7/18/2017)
view
Amarantus BioScience Holdings Inc.
(AMBS:OTCQB)
Avant Diagnostics Highlights Published Clinical Utility Data for Theralink® mTOR Pathway Activation Data Predicting Tamoxifen® and Other Endocrine Treatment Response in Estrogen Receptor Positive (ER+) Breast Cancer (7/18/2017)
view
BrainStorm Cell Therapeutics Inc.
(BCLI:NASDAQ)
BrainStorm Announces Agreements with Mass. General Hospital and California Pacific Medical Center to Participate in Phase 3 Trial of NurOwn® in ALS (7/18/2017)
view